VIRX
Asset Logo

VIRACTA THERAPEUTICS INC

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-19.82%
Annual Growth

5 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Viracta Therapeutics, Inc. is a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers, which impact patients worldwide. The Company’s lead product candidate is an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir (collectively, Nana-val). Nana-val is being evaluated in multiple ongoing clinical trials, including a pivotal, global, multicenter, open-label Phase II basket trial for the treatment of multiple subtypes of relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) lymphoma (NAVAL-1), as well as a multinational, open-label Phase Ib/II clinical trial for the treatment of patients with recurrent or metastatic (R/M) EBV + nasopharyngeal carcinoma (NPC) and other advanced EBV + solid tumors. The Company is also pursuing the application of its Kick and Kill approach in other virus-related cancers.

📈 Performance

Price History*

-99.94%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.20

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in VIRX

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

0 days

💵 Average investment amount

$1

Last time a customer invested in VIRX

876 days
VIRX investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

100%
👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in VIRX also invest in...

Silvercorp Metals Inc

SVM

🙌 Performance (5Yr p.a)

2.37%

📊 Share price

$4.62 USD
Find Out More

🙌 Performance (5Yr p.a)

11.19%

📊 Share price

$52.24 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-9.09%

📊 Share price

$9.09 USD

📊 Share price

$9.09 USD

📊 Share price

$13.40 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

13.91%

📊 Share price

$258.39 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

17.33%

📊 Share price

$31.56 USD

📈 HIGH PRICE GROWTH

Compare
Add to watchlist